Justin Lee Massengale, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catatonia | 1 | 2009 | 158 | 0.280 |
Why?
|
| Craniopharyngioma | 1 | 2009 | 281 | 0.270 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2006 | 356 | 0.220 |
Why?
|
| Sorbitol | 1 | 2002 | 59 | 0.210 |
Why?
|
| Matrix Metalloproteinase 9 | 3 | 2002 | 638 | 0.210 |
Why?
|
| Pituitary Neoplasms | 1 | 2009 | 1345 | 0.180 |
Why?
|
| Radiation Injuries | 1 | 2006 | 1180 | 0.170 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2002 | 1159 | 0.160 |
Why?
|
| Neurosurgical Procedures | 1 | 2009 | 2002 | 0.150 |
Why?
|
| Radiosurgery | 1 | 2006 | 1329 | 0.140 |
Why?
|
| Cartilage, Articular | 1 | 2023 | 1095 | 0.140 |
Why?
|
| Astrocytes | 1 | 2002 | 1273 | 0.120 |
Why?
|
| Blood-Brain Barrier | 4 | 2009 | 1019 | 0.100 |
Why?
|
| Glucose | 2 | 2009 | 4398 | 0.100 |
Why?
|
| Brain Ischemia | 2 | 2002 | 3265 | 0.090 |
Why?
|
| Ischemic Attack, Transient | 2 | 2009 | 935 | 0.080 |
Why?
|
| Lorazepam | 1 | 2009 | 145 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 480 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 489 | 0.070 |
Why?
|
| Hormones | 1 | 2009 | 889 | 0.060 |
Why?
|
| Aggrecans | 1 | 2023 | 90 | 0.060 |
Why?
|
| Collagen Type II | 1 | 2023 | 151 | 0.060 |
Why?
|
| Collagenases | 2 | 1999 | 228 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2002 | 424 | 0.050 |
Why?
|
| Hypnotics and Sedatives | 1 | 2009 | 1162 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2002 | 529 | 0.050 |
Why?
|
| Proteoglycans | 1 | 2023 | 837 | 0.050 |
Why?
|
| Brain | 2 | 2009 | 26388 | 0.050 |
Why?
|
| Culture Media | 1 | 2002 | 909 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 3511 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2009 | 3486 | 0.030 |
Why?
|
| Radiography | 1 | 2006 | 7023 | 0.030 |
Why?
|
| Psychotic Disorders | 1 | 2009 | 3046 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 1999 | 1026 | 0.030 |
Why?
|
| Cell Survival | 1 | 2002 | 5882 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2002 | 2897 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 4424 | 0.020 |
Why?
|
| Mice | 5 | 2023 | 81201 | 0.020 |
Why?
|
| Stem Cells | 1 | 2023 | 3567 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 10943 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 644 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2009 | 675 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2009 | 596 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2002 | 19233 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 547 | 0.020 |
Why?
|
| Animals | 5 | 2023 | 168768 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 627 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 18034 | 0.020 |
Why?
|
| Middle Aged | 2 | 2009 | 213390 | 0.010 |
Why?
|
| Male | 4 | 2009 | 350115 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2009 | 1525 | 0.010 |
Why?
|
| Adult | 2 | 2023 | 214052 | 0.010 |
Why?
|
| Evans Blue | 1 | 1999 | 45 | 0.010 |
Why?
|
| Benzyl Compounds | 1 | 1999 | 20 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2006 | 63107 | 0.010 |
Why?
|
| Gelatinases | 1 | 1999 | 94 | 0.010 |
Why?
|
| Succinates | 1 | 1999 | 82 | 0.010 |
Why?
|
| Pentoxifylline | 1 | 1999 | 55 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 3505 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 1999 | 149 | 0.010 |
Why?
|
| Humans | 3 | 2023 | 744366 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2006 | 77460 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2009 | 3084 | 0.010 |
Why?
|
| Oxygen | 1 | 2009 | 4189 | 0.010 |
Why?
|
| Coloring Agents | 1 | 1999 | 566 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 9735 | 0.010 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 1999 | 475 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 1999 | 11366 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1999 | 1958 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1999 | 3702 | 0.010 |
Why?
|
| Apoptosis | 1 | 2009 | 9724 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1999 | 1951 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1999 | 5181 | 0.010 |
Why?
|
| Collagen | 1 | 1999 | 2688 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1999 | 3799 | 0.010 |
Why?
|
| Female | 1 | 2006 | 380193 | 0.000 |
Why?
|